ICMR distances itself from paper on safety concerns over Covaxin
New Delhi, May 21 -- The country's apex biomedical research regulator, The Indian Council of Medical Research (ICMR), has distanced itself from the Banaras Hindu University (BHU) study that raised concerns on safety of Bharat Biotech's Covid vaccine, Covaxin, and threatened legal action against the study's authors for acknowledging ICMR's support for a poorly designed study without its consent....
To read the full article or to get the complete feed from this publication, please
Contact Us.